Position in QNCX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$324,492
-$153,571,158 QoQ
Shares Held
16,064
-93.0% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 46 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Derivatives in QNCX
reported options exposure · as of Sep 30, 2021CallValue
$91,660,000
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. QNCX ranks #308 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in QNCX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $324,492 | 16,064 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $153,895,650 | 229,695 | Shares | Defined | 2026-03-25 | |
| 2022-09-30 | $7,873,068 | 29,598 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $39,229,176 | 88,354 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $76,262,038 | 61,601 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $311,163,768 | 123,282 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $748,697,212 | 40,841 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $91,660,000 | 5,000 | Call | Defined | 2022-01-20 | |
| 2021-06-30 | $53,000,000 | 5,000 | Call | Defined | 2021-08-13 | |
| 2021-06-30 | $260,293,600 | 24,556 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $149,012,874 | 20,679 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $269,404,884 | 48,489 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $380,880,000 | 38,088 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $358,047,160 | 38,666 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||